Ikarian Capital »

Miragen Therapeutics shares owned by Ikarian Capital

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $4.9M 3.8k 1301.00
2024-03-31 $3.1M 179k 17.51
2022-06-30 $3.5M 300k 11.57

More positions owned by Ikarian Capital

Sarepta Therapeutics Call Option (SRPT)
Amgen Call Option (AMGN)
Bridgebio Pharma Call Option (BBIO)
Immunovant Call Option (IMVT)
Neurocrine Biosciences Call Option (NBIX)
Pyxis Oncology Common Stock Call Option (PYXS)
Insmed Com Par $.01 Call Option (INSM)
Abeona Therapeutics Com New Call Option (ABEO)
Alnylam Pharmaceuticals Put Option (ALNY)
Aerovate Therapeutics Call Option (AVTE)
Rapt Therapeutics Call Option (RAPT)
Praxis Precision Medicines I Com New Call Option (PRAX)
Crinetics Pharmaceuticals In (CRNX)
Tarsus Pharmaceuticals (TARS)
Soleno Therapeutics (SLNO)

View all positions for Ikarian Capital

Top funds holding Miragen Therapeutics

BlackRock
Deep Track Capital
VR Adviser
Vanguard Group
Maverick Capital
Paradigm Biocapital Advisors
State Street Corporation
Commodore Capital
Novo A/S
Alliancebernstein
Fairmount Funds Management
Kynam Capital Management
Perceptive Advisors
Geode Capital Management
Tang Capital Management

View all funds holding Miragen Therapeutics